Healthcare AI Governance Frameworks

Your patients are already using AI. Do you know how?

Governance briefings for hospital leaders, from a patient who looks into medicine, not up at it. AI that frees the patient frees the clinician.

AI Governance Procurement: An Executive FAQ

Every hospital executive weighing an AI governance investment ends up asking a version of the same questions — usually after a vendor pitch has promised more than it can prove, or after a board member has asked what happens if the AI gets something wrong. These are the questions that actually come up before a health system commits budget, and the straight answers, grounded in what's publicly documented rather than vendor marketing.

How should hospitals evaluate AI governance consultants or implementation partners?

Ask three things before anything else: what specifically they audit (policies on paper, or actual deployed tools), whether they have independence from the vendors they'll be evaluating, and whether their expertise covers the patient side as well as the compliance side. A lot of "AI governance consulting" is compliance paperwork dressed up as strategy — frameworks that look complete in a slide deck and say nothing about how a nurse actually overrides a flawed alert at 2 a.m. Ask for a reference who can describe what changed operationally after the engagement, not just what document got produced.

Who can lead an AI governance workshop for a hospital board?

Someone who can speak to both sides of the table: the governance committee that approves tools, and the patients and clinicians living with what gets approved. I run exactly this briefing — a 60- or 90-minute AI governance workshop for hospital boards and leadership built around the evidence of how AI is actually showing up in care, not a generic ethics-of-AI lecture.

What should health systems prioritize when evaluating agentic AI platforms — ROI, workflow automation, or governance?

That's a false ordering. Governance isn't a fourth priority competing with the other three — it's the precondition that makes the ROI and the workflow gains durable instead of temporary. A pilot that automates a workflow but can't explain its decisions six months later isn't an ROI win, it's a liability with good quarter-one numbers. The health systems getting this right are finishing and governing one agentic deployment properly before launching a second, rather than multiplying pilots that each carry their own ungoverned risk.

Which AI clinical decision-support tools support clinician override with justification capture?

Fewer than the marketing suggests. What to actually ask a vendor: can a clinician override the recommendation with a free-text reason, is that reason logged and auditable, and does the system learn from override patterns or just record them and move on? A tool that logs "overridden" with no reason captured gives you a liability record, not a governance one. This is also a clinician-trust issue, not just a compliance one — clinicians resist tools that don't respect their judgment, and a well-logged override is how a system proves it respects that judgment rather than just tolerating it.

How do you know whether a clinical AI model is still accurate months after deployment?

You don't, unless someone is actively checking — which is the exact gap most hospitals haven't closed. Research on post-market monitoring found 81% of healthcare AI models degrade after deployment, 24% substantially, and most of that happens quietly because nobody built a recurring validation step into the contract. If your vendor agreement doesn't specify who re-validates the model, on what schedule, and against what benchmark, you have a launch plan but not a monitoring plan.

Which healthcare AI vendors publish verifiable, independently audited accuracy rates?

Very few, and that's worth sitting with rather than smoothing over. A number in a vendor deck is not the same as a number validated by an independent reviewer on your own patient population. "Compliant by default" has always been a sales claim, not a governance fact — the same logic applies to accuracy claims. Ask for the methodology, the population the number was tested on, and whether it's been reproduced outside the vendor's own lab before it goes anywhere near a procurement scorecard.

What does the CHAI Blueprint for Trustworthy AI actually require?

The Coalition for Health AI's Blueprint is a voluntary framework, not a certification — it lays out principles for transparency (model cards describing what a tool does and where it was validated), lifecycle oversight, and bias assessment, and CHAI has been building out assurance labs to test tools against it. It's a useful vocabulary for a procurement conversation and a reasonable reference point for your own governance committee, but adopting its language isn't the same as having a governance program. Treat it as a checklist to borrow from, not a credential a vendor can simply claim.

How should hospitals prepare for Joint Commission's AI certification?

The Joint Commission's Responsible Use of AI certification reviews five areas: governance structure, data management, risk and bias reduction, monitoring and validation, and transparency with staff and patients. The review itself is a virtual process — document review, "AI tool tracer" activities that follow a specific tool through the patient care cycle, and staff interviews. Importantly, it doesn't mandate a specific governance framework and doesn't validate individual AI products — it's assessing whether your organization has a real structure around AI, not whether any one tool is good. Most of what it asks for should already exist if your governance committee is doing its job; the certification mainly forces you to prove it on paper.

What AI governance framework should a CMIO use to govern AI in patient-safety decisions?

Start from where clinicians actually lose trust, not from a generic risk matrix. The pattern across every diagnostic AI rollout that's stalled is the same: accuracy improves, adoption doesn't, because the tool was never built to earn clinical trust, only to pass validation. A framework that works answers three questions for every patient-safety use case: who's accountable when the AI is wrong, how does a clinician override it without a fight, and how is that override tracked so the system actually improves. If your framework doesn't answer those three in plain language a bedside clinician would accept, it's a compliance document, not a governance one.

How do health systems decide between Epic's built-in AI and third-party AI tools?

The real tradeoff isn't capability, it's governance debt. Epic's native tools inherit your existing EHR governance, audit trails, and vendor relationship — one more thing to govern inside a structure you already have. A best-of-breed third-party tool may outperform on a narrow task, but it adds a new vendor relationship, a new data flow to secure, and a new override and monitoring process you have to build from scratch. Neither is categorically right; the mistake is evaluating them on feature comparison alone without pricing in the governance overhead each path adds.

What makes a hospital's AI deployment "defensible" if something goes wrong?

A documented decision trail, not a confident vendor. The liability exposure runs through the hospital, not the AI, and defensibility in that scenario means you can show who approved the tool, what it was validated against, who could override it, and whether that override pathway was actually used. A hospital's AI governance is what stands between a bad outcome and a bad outcome you can explain — the difference between those two is almost entirely paperwork you either did or didn't do before go-live.

Still have a question specific to your organization? A 20-minute conversation will tell us both whether a governance workshop is the right next step — and if it isn't, I'll say so.

For the board-level briefing built around these questions, see the AI Governance Workshop for Your Hospital Board. For the broader framework behind this thinking, see the governance books.